Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Sci Rep. 2021 Feb 2;11(1):2751. doi: 10.1038/s41598-021-81895-0.
Sci Rep. 2021.
PMID: 33531570
Free PMC article.